Drug balloon dilatation catheter and interventional medical instrument
By introducing blood flow channels into the drug balloon dilated catheter, the problem of blood flow blockage when the drug balloon expands is solved, ensuring blood circulation and achieving effective drug release, reducing surgical risks.
Patent Information
- Application Number
- CN202411535806.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-31
- Publication Date
- 2024-11-29
AI Technical Summary
Existing drug balloon dilated catheters block blood flow when they are charged and expanded for a long time to compress and dilate the stenotic lesion area, increasing the risk of surgery in patients.
A drug balloon dilation catheter is designed, including a tube body, a balloon, a drug coating, a delivery channel and a blood flow channel. The delivery channel and the blood flow channel are isolated from each other. After the balloon expands, the blood vessels can be blocked, but the blood flow channel is Connect the upstream and downstream of the balloon to ensure blood circulation and avoid blood flow blockage.
It is achieved that the drug balloon can maintain blood circulation after expansion, reduce surgical risks, ensure effective release of the drug to the narrow lesion area, and the balloon can be safely recovered after release is completed.
Smart Images

Figure CN119034088A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of interventional medical devices, and more specifically, relates to a drug balloon dilatation catheter and an interventional medical device. Background Art
[0002] For patients with coronary artery or peripheral vascular stenosis, the current general treatment method is percutaneous transluminal angioplasty. With the development of surgical procedures, the call for "interventional non-implantation" treatment of cardiovascular disease is getting higher and higher. As a representative treatment device of "interventional non-implantation", drug-eluting balloons are increasingly used in clinical practice. Specifically, drug-eluting balloons are coated with special drugs (such as anti-endothelial hyperplasia, anti-inflammatory drugs, etc.) on the balloon membrane of the balloon dilatation catheter, and the drug-eluting balloon is delivered to the target stenotic lesion through the drug-eluting balloon dilatation catheter, and then the drug-eluting balloon is expanded. While the drug-eluting balloon expands and opens the lesion, the drug on the surface of the balloon membrane will fit closely with the vascular endothelium, and release the drug to the target stenotic lesion during the continuous adhesion process. After the drug is fully absorbed by the stenotic lesion, the drug-eluting balloon dilatation catheter is withdrawn. In this way, drug-eluting balloons achieve blood supply reconstruction through the dual treatment of physical expansion and drug inhibition of restenosis. Drug-eluting balloons have been confirmed by many clinical studies for their efficacy and safety in complex lesions, small vessel lesions, bifurcation lesions, and in-stent restenosis lesions. Compared with stents, its advantage is that it can achieve interventional treatment without implantation.
[0003] See also Figure 1 The currently used drug balloon dilatation catheter has a balloon 2' that is cylindrical after expansion (i.e., the balloon is in an expanded state), and the guide wire passes through the inside of the balloon. When the drug balloon expands, the balloon membrane will fit tightly with the inner membrane of the blood vessel over the entire circumference of 360°. At this time, the lumen of the blood vessel in the balloon expansion area is completely closed, and the blood flow in the blood vessel is blocked, resulting in ischemia of the distal myocardium or tissue. In actual operation, in order to ensure that the drug on the surface of the balloon membrane is fully in contact with and released from the lesion, it is usually necessary to keep the drug balloon in an expanded state for a long time (if ≥1min), which will cause the patient's distal myocardium or tissue to be in an ischemic state for a long time, thereby increasing the patient's surgical risk. Summary of the invention
[0004] The purpose of the present invention is to provide a drug balloon dilatation catheter to solve the technical problem that the drug balloon dilatation catheter currently used in clinical practice will block blood flow during long-term pressurization and dilation of a stenotic lesion area.
[0005] To achieve the above-mentioned purpose, the technical solution adopted by the present invention is: to provide a drug balloon dilatation catheter, comprising: a tube body, a balloon arranged on the tube body, and a drug coating coated on the surface of the balloon; a delivery channel and a blood flow channel are arranged in the tube body; the delivery channel and the blood flow channel are isolated from each other; the balloon has a accommodating cavity, and the delivery channel is connected to the accommodating cavity; the blood flow channel is isolated from the accommodating cavity; the blood flow channel comprises: a blood flow inlet for communicating with the blood vessel upstream of the balloon and a blood flow outlet for communicating with the blood vessel downstream of the balloon.
[0006] Furthermore, from the proximal end to the distal end of the tube body, the delivery channel and the blood flow channel are sequentially formed by the inner cavity of the tube body.
[0007] Furthermore, the blood flow channel runs through the balloon, the blood flow inlet is opened on the side wall of the tube body behind the balloon, and the blood flow outlet is opened on the side wall of the tube body in front of the balloon.
[0008] Further, the tube body comprises: a first tube and a second tube; the two ends of the first tube are respectively a first end and a second end; the tube cavity in the first tube forms the delivery channel; the two ends of the second tube are respectively a third end and a fourth end; the tube cavity in the second tube forms the blood flow channel; the delivery channel comprises: a delivery inlet and a delivery outlet; the delivery inlet is located on the first end, and the delivery outlet is located on the second end; the blood flow inlet is located on the third end, and the blood flow outlet is located on the fourth end; a through hole is provided on the side wall of the first tube; the third end extends into the delivery channel through the delivery outlet, and the edge of the blood flow inlet is sealed and fixedly connected to the edge of the through hole; the blood flow inlet is connected to the external space of the first tube through the through hole; the balloon is arranged on the first tube and / or the second tube, and the accommodating cavity is connected to the delivery outlet; the blood flow inlet is located behind the balloon, and the blood flow outlet is located in front of the balloon.
[0009] Furthermore, the balloon has a cylindrical body; the two ends of the cylindrical body are respectively a first opening and a second opening; the edge of the first opening is sleeved and fixed on the outer wall of the first tube, or the edge of the first opening is sealed and fixedly connected to the edge of the delivery outlet; the edge of the second opening is sleeved and fixed on the outer wall of the second tube; the accommodating cavity connected to the delivery outlet is formed between the inner wall of the balloon body and the outer wall of the second tube.
[0010] Furthermore, the accommodating cavity surrounds the outside of the blood flow channel.
[0011] Furthermore, the balloon and the tube body are an integrated piece.
[0012] Furthermore, the cross-section of the blood flow channel may be in any one of a circular, semicircular, elliptical and polygonal shape.
[0013] Furthermore, the shape of the blood flow outlet can be any one of circular, semicircular, elliptical and polygonal.
[0014] Furthermore, it also includes: a first guide channel for a guide wire to pass through; the first guide channel is arranged on the fourth end; the first guide channel is isolated from the blood flow channel.
[0015] Furthermore, the fourth end is located on an extension path of the blood flow channel, and the blood flow outlet is opened on a side wall of the fourth end.
[0016] Furthermore, the number of the blood flow outlets is one or more.
[0017] Furthermore, the plurality of blood flow outlets are arranged evenly or randomly.
[0018] Furthermore, at least two of the blood flow outlets are oriented in the same direction.
[0019] Furthermore, at least two of the blood flow outlets are arranged around and in sequence at intervals outside the blood flow channel; and in the direction surrounding the blood flow channel, the directions of any two adjacent blood flow outlets are arranged at an acute angle.
[0020] Furthermore, the fourth end and the balloon are an integral piece.
[0021] Furthermore, it also includes: a guide wire and a first guide channel for the guide wire to pass through; the first guide channel is arranged on the fourth end; and the guide wire is passed through the first guide channel.
[0022] Furthermore, it also includes: a first guide tube arranged on the fourth end; the inner space of the first guide tube forms the first guide channel.
[0023] Further, at least part of the first guide tube is arranged in parallel with the blood flow channel; or The first guide tube is located in front of the blood flow channel.
[0024] Furthermore, the first guide tube and the fourth end are an integral piece.
[0025] Furthermore, it also includes: a second guide channel arranged on the balloon and used for the guide wire to pass through.
[0026] Furthermore, the second guide channel passes through the interior of the balloon, and the second guide channel and the accommodating cavity are isolated from each other.
[0027] Furthermore, the second guide channel is located outside the balloon.
[0028] Furthermore, a second guide tube is provided on the outer surface of the balloon, and the inner space of the second guide tube forms the second guide channel.
[0029] Furthermore, after the balloon is deflated, it can surround and cover the outside of the second guide channel.
[0030] Furthermore, the balloon can be folded into a plurality of petals after being deflated; one or more of the petals can be wrapped around the outside of the second guide channel.
[0031] Furthermore, each of the valve bodies has a chamber connected to the balloon.
[0032] Furthermore, each chamber has a first inner wall and a second inner wall respectively; the first inner wall and the second inner wall can fit together under external pressure to discharge the fluid in the chamber.
[0033] Furthermore, after the balloon is deflated, the plurality of valve bodies can be folded in a spiral manner.
[0034] Furthermore, the outer surface of the balloon is concave to form a groove for the guide wire to pass through, and the inner space of the groove forms the second guide channel.
[0035] Furthermore, a flexible sheet is laid on the inner wall of the groove.
[0036] The present invention also provides an interventional medical device, comprising: a pressure source and the drug balloon dilatation catheter; the pressure source is connected to the delivery channel.
[0037] The beneficial effects of the drug balloon dilatation catheter provided by the present invention are as follows: compared with the prior art, the drug balloon dilatation catheter provided by the present invention has a tube body with a delivery channel, a tube body with a blood flow channel, and the delivery channel and the blood flow channel are isolated from each other; a balloon is arranged on the tube body, and a containing cavity is arranged in the balloon, and the delivery channel and the containing cavity are communicated; liquid (or gas) is injected into the containing cavity of the balloon through the delivery channel to make the balloon expand; before the balloon expands, the user can deliver the balloon into the blood vessel; after the balloon expands, the blood vessel can be blocked; the outer surface of the balloon has a drug coating, and when the balloon expands, the drug coating on the surface of the balloon can contact the lesion area on the inner wall of the blood vessel, so that the drug on the drug coating can be released to the lesion area on the inner wall of the blood vessel; the blood flow inlet of the blood flow channel can be communicated with the upstream blood vessel of the balloon, and the blood flow outlet of the blood flow channel can be communicated with the downstream blood vessel of the balloon, so that after the balloon blocks the blood vessel, the blood upstream of the balloon can still enter the downstream of the balloon through the blood flow channel, thereby avoiding the blocking of blood flow in the blood vessel during the process of the drug coating on the balloon contacting the narrow lesion area and releasing the drug. In addition, after the drug coating on the balloon has completed releasing the drug to the stenotic lesion area, if the liquid (or gas) in the balloon is discharged through the delivery channel, the deflated balloon can be removed from the blood vessel. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
[0039] Figure 1 A schematic cross-sectional view of a drug balloon dilatation catheter in the prior art provided by an embodiment of the present invention; Figure 2 A schematic cross-sectional view of a drug balloon dilatation catheter provided in an embodiment of the present invention; Figure 3 A cross-sectional view of a drug balloon dilatation catheter provided in an embodiment of the present invention Figure 1 (blood vessels and lesions are hidden); Figure 4 A cross-sectional view of the combination of a drug balloon dilatation catheter and a guide wire provided in an embodiment of the present invention Figure 1 (blood vessels and lesions are hidden); Figure 5 for Figure 3 A magnified view of the A-section structure; Figure 6 For along Figure 3 The cross-sectional structure diagram of the middle BB line; Figure 7 For along Figure 3Cross-sectional structural diagram of the center CC line; Figure 8 For along Figure 3 Cross-sectional structural diagram of the middle DD line; Fig. 9 For along Figure 3 The cross-sectional structure diagram of the EE line; Fig.10 for Figure 4 A magnified view of the K-section structure; Fig.11 A cross-sectional view of a drug balloon dilatation catheter provided in an embodiment of the present invention Figure 2 (blood vessels and lesions are hidden); Fig.12 A cross-sectional view of the combination of a drug balloon dilatation catheter and a guide wire provided in an embodiment of the present invention Figure 2 (blood vessels and lesions are hidden); Fig.13 For along Fig.11 Cross-sectional structure of the middle HH line Figure 1 (The balloon is inflated); Fig.14 For along Fig.11 Cross-sectional structure of the middle HH line Figure 2 (The balloon is inflated); Fig.15 For along Fig.11 Cross-sectional structure of the middle HH line Figure 3 (The balloon is in the deflated state); Fig.16 For along Fig.11 Cross-sectional structure of the middle HH line Figure 4 (The balloon is in the deflated state); Fig.17 For along Fig.11 Cross-sectional structure of the middle HH line Figure 5 (The balloon is in a deflated state and the valve is spread out flat); Fig.18 For along Fig.11 Cross-sectional structure of the middle HH line Figure 2 (The balloon is inflated); Fig.19 A cross-sectional view of a drug balloon dilatation catheter provided in an embodiment of the present invention Figure 2 (The dotted arrow in the figure indicates the direction of blood flow); Fig. 20 for Fig.19 A' in the middle is an enlarged schematic diagram (the dotted arrow in the figure indicates the direction of blood flow); Fig.21 for Fig.19 The enlarged schematic diagram at B' in the middle; Fig. 22 for Fig.19 The enlarged schematic diagram of the C' in the middle (the dotted arrow in the figure indicates the direction of blood flow); Fig.23 A cross-sectional view of the combination of a drug balloon dilatation catheter and a guide wire provided in an embodiment of the present invention Figure 3 (The dotted arrow in the figure indicates the direction of blood flow); Fig.24 for Fig.23 Schematic diagram of hidden guidewire (the dotted arrow in the figure indicates the direction of blood flow); Fig.25 for Fig.24 Schematic diagram of the D`-D` section; Fig.26 for Fig.24 Schematic diagram of the E`-E` section.
[0040] Among them, the reference numerals in the figure are: 1-tube body; 11-first tube; 111-first end; 112-second end; 113-delivery channel; 1131-delivery inlet; 1132-delivery outlet; 114-through hole; 12-second tube; 121-third end; 122-fourth end; 123-blood flow channel; 1231-blood flow inlet; 1232-blood flow outlet; 2, 2`-balloon; 21-accommodating cavity; 22-valve body; 23-groove; 3-drug coating; 41, 41`-guide wire; 42-first guide tube; 421-first guide channel; 4211-guide outlet; 5-second guide tube; 51-second guide channel; 6, 6`-blood vessel; 61, 61`-lesion area; 7-flexible sheet. DETAILED DESCRIPTION
[0041] It should be noted that the specific embodiments are only used to explain the present invention, and are not used to limit the present invention.
[0042] It should be noted that, in the description of the embodiments of the present application, unless otherwise specified, " / " means or, for example, A / B can mean A or B; "and / or" in this article is only a description of the association relationship of associated objects, indicating that there can be three relationships, for example, A and / or B can mean: A exists alone, A and B exist at the same time, and B exists alone. Among them, A and B can be singular or plural respectively.
[0043] It should be noted that when an element is referred to as being "fixed on" or "set on" another element, it may be directly on the other element or indirectly on the other element. When an element is referred to as being "connected to" or "connected to" another element, it may be directly connected to the other element or indirectly connected to the other element. When an element is referred to as being "fixed on" or "set on" another element, it may be directly on the other element or indirectly on the other element.
[0044] It should be noted that the directions or positional relationships indicated by terms such as “length”, “width”, “up”, “down”, “front”, “back”, “left”, “right”, “vertical”, “horizontal”, “top”, “bottom”, “inside” and “outside” are based on the directions or positional relationships shown in the accompanying drawings and are only for the convenience of describing the present invention and simplifying the description. They do not indicate or imply that the device or element referred to must have a specific direction, be constructed and operated in a specific direction. Therefore, they should not be understood as limiting the present invention.
[0045] It should be noted that the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, features defined as "first" and "second" may explicitly or implicitly include one or more of the features.
[0046] It should be noted that the term "plurality" means two or more than two, unless otherwise clearly and specifically defined.
[0047] The "distal end" can be understood as the front end of the tube 1 in the direction of entering the blood vessel. The "proximal end" can be understood as the other end opposite to the "distal end". In actual operation, the "proximal end" is the end close to the human hand.
[0048] The “front” may be understood as the direction in which the tube body 1 enters the blood vessel, and the “rear” may be understood as another direction opposite to the “front” mentioned above.
[0049] Please also read Figures 2 to 10 The drug balloon dilatation catheter provided by the present invention is now described. The drug balloon dilatation catheter comprises: a tube body 1, a balloon 2 arranged on the tube body 1, and a drug coating 3 coated on the surface of the balloon 2; a delivery channel 113 and a blood flow channel 123 are arranged in the tube body 1; the delivery channel 113 and the blood flow channel 123 are isolated from each other; the balloon 2 has a receiving cavity 21, and the delivery channel 113 is connected to the receiving cavity 21; the blood flow channel 123 is isolated from the receiving cavity 21; the blood flow channel 123 comprises: a blood flow inlet 1231 for communicating with the blood vessel 6 upstream of the balloon 2 and a blood flow outlet 1232 for communicating with the blood vessel 6 downstream of the balloon 2.
[0050] Thus, the tube body 1 has a delivery channel 113, and the tube body 1 has a blood flow channel 123, and the delivery channel 113 and the blood flow channel 123 are isolated from each other; a balloon 2 is arranged on the tube body 1, and a receiving chamber 21 is arranged in the balloon 2, and the delivery channel 113 and the receiving chamber 21 are communicated; liquid (or gas) is injected into the receiving chamber 21 of the balloon 2 through the delivery channel 113 to expand the balloon 2; before the balloon 2 expands, the user can deliver the balloon 2 to the blood vessel 6; after the balloon 2 expands, the blood vessel 6 can be blocked; the outer surface of the balloon 2 has a drug coating 3, and when the balloon 2 is expanded, the surface of the balloon 2 The drug coating 3 on the surface can contact the lesion area 61 on the inner wall of the blood vessel 6, so that the drug on the drug coating 3 can be released to the lesion area 61 on the inner wall of the blood vessel 6; the blood flow inlet 1231 of the blood flow channel 123 can be connected to the upstream blood vessel 6 of the balloon 2, and the blood flow outlet 1232 of the blood flow channel 123 can be connected to the downstream blood vessel 6 of the balloon 2, so that after the balloon 2 blocks the blood vessel 6, the blood upstream of the balloon 2 can still enter the downstream of the balloon 2 through the blood flow channel 123, avoiding the blocking of blood flow in the blood vessel 6 during the process of the drug coating 3 on the balloon 2 contacting the stenotic lesion area 61 and releasing the drug. In addition, after the drug coating 3 on the balloon 2 has released the drug to the stenotic lesion area 61, if the liquid (or gas) in the balloon 2 is discharged through the delivery channel 113, the deflated balloon 2 can be taken out of the blood vessel 6.
[0051] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon 2 dilatation catheter provided by the present invention, from the proximal end to the distal end of the tube body 1, the inner cavity of the tube body 1 sequentially forms a delivery channel 113 and a blood flow channel 123. In this way, the delivery channel 113 and the blood flow channel 123 are sequentially arranged along the tube body 1, which is convenient for space utilization.
[0052] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon 2 dilatation catheter provided by the present invention, the blood flow channel 123 penetrates the balloon 2, the blood flow inlet 1231 is opened on the side wall of the tube body 1 behind the balloon 2, and the blood flow outlet 1232 is opened on the side wall of the tube body 1 in front of the balloon 2. In this way, blood can flow through the balloon 2 through the blood flow channel 123.
[0053] For further information, see Figures 2 to 10As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the tube body 1 includes: a first tube 11 and a second tube 12; the two ends of the first tube 11 are respectively a first end 111 and a second end 112; the lumen in the first tube 11 forms a delivery channel 113; the two ends of the second tube 12 are respectively a third end 121 and a fourth end 122; the lumen in the second tube 12 forms a blood flow channel 123; the delivery channel 113 includes: a delivery inlet 1131 and a delivery outlet 1132; the delivery inlet 1131 is located on the first end 111, and the delivery outlet 1132 is located on the first end 111. 2 is located on the second end 112; the blood flow inlet 1231 is located on the third end 121, and the blood flow outlet 1232 is located on the fourth end 122; a through hole 114 is opened on the side wall of the first tube 11; the third end 121 extends into the delivery channel 113 through the delivery outlet 1132, and the edge of the blood flow inlet 1231 is sealed and fixedly connected with the edge of the through hole 114; the blood flow inlet 1231 is connected to the external space of the first tube 11 through the through hole 114; the balloon 2 is arranged on the first tube 11 and / or the second tube 12, and the accommodating cavity 21 is connected with the delivery outlet 1132. In one embodiment, the blood flow inlet 1231 is located behind the balloon 2, and the blood flow outlet 1232 is located in front of the balloon 2. In this way, the lumen in the first tube 11 forms a delivery channel 113, and a through hole 114 is opened on the side wall of the first tube 11; the third end 121 of the second tube 12 extends into the delivery channel 113 from the delivery outlet 1132, and the edge of the blood flow inlet 1231 on the third end 121 is sealed and fixedly connected to the edge of the through hole 114, and the external blood can enter the blood flow inlet 1231 through the through hole 114, and the blood entering the blood flow inlet 1231 can be transported along the blood flow channel 123, and the blood in the blood flow channel 123 can be discharged from the blood flow outlet 1232; the first tube 11 can protect the second tube 12 located inside the first tube 11.
[0054] In one embodiment, the fourth end 122 of the second tube 12 is located outside the delivery channel 113 .
[0055] For further information, see Figures 2 to 10As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the balloon 2 has a cylindrical balloon body; the two ends of the cylindrical balloon body are respectively a first opening and a second opening; the edge of the first opening is sleeved and fixed on the outer wall of the first tube 11, or the edge of the first opening is sealed and fixedly connected with the edge of the delivery outlet 1132; the edge of the second opening is sleeved and fixed on the outer wall of the second tube 12; a receiving cavity 21 connected to the delivery outlet 1132 is formed between the inner wall of the balloon body and the outer wall of the second tube 12. In this way, it is very convenient to fix the balloon body, and it is only necessary to sleeve and fix the first opening edge of the balloon body on the outer wall of the first tube 11 (or the first opening edge is fixedly connected with the edge of the delivery outlet 1132), and sleeve and fix the second opening edge of the balloon body on the outer wall of the second tube 12; the delivery channel 113 can input liquid (or gas) into the receiving cavity 21 to expand the balloon body.
[0056] In one embodiment, the first opening edge is fixed to the outer wall of the first tube 11 by welding.
[0057] In one embodiment, the second opening edge is fixed to the outer wall of the second tube 12 by welding.
[0058] In one embodiment, the blood flow inlet 1231 is provided on the tube body 1 outside the proximal end of the balloon 2, and the distance from the proximal welding point of the balloon 2 is preferably not greater than 10 cm, that is, less than or equal to 10 cm. In addition, the blood flow outlet 1232 is preferably provided on the fourth end 122 of the tube body 1 outside the distal end of the balloon 2. The blood flows into the blood flow channel 123 inside the tube body 1 from the blood flow inlet 1231, and flows out through the blood flow outlet 1232.
[0059] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the accommodating chamber 21 surrounds the outside of the blood flow channel 123. In this way, the accommodating chamber 21 can protect the blood flow channel 123 from the outside of the blood flow channel 123.
[0060] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the balloon 2 and the tube body 1 are integrated. In this way, the balloon 2 and the tube body 1 are more secure.
[0061] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the cross-sectional shape of the blood flow channel 123 can be any one of circular, semicircular, elliptical and polygonal.
[0062] For further information, see Figures 2 to 10As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the shape of the blood flow outlet 1232 can be any one of circular, semicircular, elliptical and polygonal.
[0063] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the number of the blood flow outlets 1232 is one or more. In this way, the blood in the blood flow channel 123 can be dispersedly discharged from the multiple blood flow outlets 1232.
[0064] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the multiple blood flow outlets 1232 are arranged evenly or randomly. In this way, the blood flow output from the multiple blood flow outlets 1232 is more uniform.
[0065] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, at least two blood flow outlets 1232 are oriented in the same direction. In this way, the blood in the blood flow channel 123 is not likely to interfere with each other when being discharged from the blood flow outlets oriented in the same direction.
[0066] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, at least two blood flow outlets 1232 are arranged around and spaced apart from each other on the outside of the blood flow channel 123; and in the direction around the blood flow channel 123, the directions of any two adjacent blood flow outlets 1232 are arranged at an acute angle. In this way, the blood in the blood flow channel 123 can be discharged to the outside through different blood flow outlets 1232 at an acute angle, reducing the mutual interference between the blood flows discharged from different blood flow outlets 1232.
[0067] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the fourth end 122 and the balloon 2 are integrated. In this way, the fourth end 122 and the balloon 2 are more firmly connected.
[0068] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, it also includes: a guide wire 41 and a first guide channel 421 for the guide wire 41 to pass through; the first guide channel 421 is arranged on the fourth end 122; the first guide channel 421 is isolated from the blood flow channel 123; the guide wire 41 is inserted into the first guide channel 421. In this way, the guide wire 41 can pass through the first guide channel 421 to play a guiding role, so that the balloon 2 can enter the blood vessel 6 along the guide wire 41; the first guide channel 421 is arranged on the fourth end 122, reducing the influence of the balloon 2 on the guide wire 41 passing through the first guide channel 421.
[0069] In one embodiment, it further includes: a first guide channel 421 for the guide wire 41 to pass through; the first guide channel 421 is arranged on the fourth end 122. In this way, the guide wire 41 can pass through the first guide channel 421 to guide the balloon 2 along the guide wire 41 into the blood vessel 6; the first guide channel 421 is arranged on the fourth end 122 to reduce the influence of the balloon 2 on the guide wire 41 passing through the first guide channel 421.
[0070] In one embodiment, the first guide channel 421 has a guide outlet 4211 at one end close to the balloon 2 .
[0071] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, it also includes: a first guide tube 42 disposed on the fourth end 122; the internal space of the first guide tube 42 forms a first guide channel 421. In this way, it is very convenient for the guide wire 41 to pass through the first guide tube 42.
[0072] In one embodiment, in order to ensure that the balloon 2 on the tube body 1 can smoothly reach the stenotic lesion in the blood vessel, a first guide tube 42 for connecting the guide wire 41 is arranged outside the fourth end 122, and the drug balloon 2 is delivered to the target stenotic lesion area 61 under the guidance of the guide wire 41. Since the first guide tube 42 is arranged on the fourth end 122, on the one hand, it can avoid squeezing the first guide tube 42 when the balloon 2 is expanded, causing the first guide tube 42 to be flattened or collapsed, and prevent the guide wire 41 from being locked in the first guide tube 42, so that the balloon 2 catheter can be smoothly withdrawn from the blood vessel along the guide wire 41 when the operation is completed. On the other hand, it can avoid that the first guide tube 42 increases the cross-section of the entire balloon 2, effectively ensuring the passability of the balloon 2 in the stenotic lesion in the blood vessel.
[0073] In one embodiment, a first guide tube 42 is disposed on the fourth end 122 , and the length of the first guide tube 42 may preferably be set at 0.5-1.5 cm to adapt to the threading of the guide wire 41 , which is beneficial to improving the operational flexibility of activities in the blood vessel.
[0074] In one embodiment, the working principle of the drug balloon dilatation catheter provided in the embodiment of the present application is as follows: first, the proximal end of the guide wire 41 is inserted into the tube opening of the distal end of the first guide tube 42 and exits from the tube opening of the proximal end of the first guide tube 42, so that the first guide tube 42 on the distal end of the balloon 2 is completely covered on the guide wire 41, and then the guide wire 41 and the balloon 2 are sent into the blood vessel 6 together, and the guide wire 41 is delivered forward until the distal end of the guide wire 41 passes through the stenosis lesion in the blood vessel 6, and finally, under the guidance of the guide wire 41, the balloon 2 is delivered to the target stenosis lesion area 61; secondly, the balloon 2 is pressurized and expanded. During the continuous pressurization and expansion process, the balloon 2 will gradually contact the endothelium of the blood vessel 6. While expanding and opening the stenosis lesion, the drug coating on the surface of the balloon 2 will fit tightly with the endothelium of the blood vessel 6. The balloon 2 is kept in the inflated and expanded state for a certain period of time, so that the drug on the surface of the balloon 2 is fully released to the inner membrane of the blood vessel 6; finally, during the period of time when the balloon 2 is in the inflated and expanded state, the balloon 2 and the inner membrane of the blood vessel 6 are closely attached, and there is no space between the two for blood flow to pass through. At this time, the blood flow in the blood vessel 6 can enter the blood flow channel 123 from the blood flow inlet 1231, and the blood flow in the blood flow channel 123 can flow out from the blood flow outlet 1232. Allowing the blood flow to flow through the expanded (i.e., inflated) area of the balloon 2 through the blood flow channel 123 can prevent the patient from having myocardial infarction or other adverse clinical symptoms due to myocardial or tissue ischemia during the operation.
[0075] For further information, see Figures 19 to 26 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, at least part of the first guide tube 42 is arranged parallel to the blood flow channel 123. In this way, when the fourth end 122 moves relative to the guide wire 41, the stress of the guide wire 41 and the fourth end 122 can be transmitted along the extension direction of the blood flow channel 123.
[0076] See also Figures 2 to 10 , the first guide tube 42 is located in front of the blood flow channel 123. In this way, the guide wire 41 passing through the first guide tube 42 can be guided in front of the blood flow channel 123.
[0077] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the first guide tube 42 and the fourth end 122 are integrated. In this way, the first guide tube 42 and the tube body 1 are more firmly connected.
[0078] For further information, see Figures 2 to 10 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, it also includes: a second guide channel 51 provided on the balloon 2; the guide wire 41 passes through the second guide channel 51. In this way, the guide wire 41 can pass through the second guide channel 51 on the balloon 2, and the second guide channel 51 can provide a delivery space for the guide wire 41.
[0079] For further information, see Fig.13 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the second guide channel 51 passes through the interior of the balloon 2, and the second guide channel 51 is isolated from the accommodating cavity 21. In this way, the guide wire 41 is not likely to interfere with the substances outside the balloon 2 when passing through the second guide channel 51.
[0080] For further information, see Fig.14 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the second guide channel 51 is located outside the balloon 2. In this way, the second guide channel 51 is prevented from occupying the internal space of the balloon 2.
[0081] For further information, see Fig.14 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, a second guide tube 5 is provided on the outer surface of the balloon 2, and the inner space of the second guide tube 5 forms a second guide channel 51. In this way, the second guide channel 51 is formed in the second guide tube 5, and the structure is simple; the second guide tube 5 does not occupy the inner space of the balloon 2.
[0082] For further information, see Figures 11 to 15 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the balloon 2 can wrap around the outside of the second guide channel 51 after being deflated. In this way, the balloon 2 can fold around the outside of the second guide channel 51 after being deflated to protect the guide wire 41 in the second guide channel 51.
[0083] For further information, see Fig.15 and Fig.17 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the balloon 2 can be folded into multiple petals 22 after being deflated; one or more petals 22 can be wrapped around the outside of the second guide channel 51. In this way, multiple petals 22 can be wrapped around the outside of the second guide channel 51 for protection; after the balloon 2 is deflated, it can be folded into multiple petals 22, which can facilitate the storage of the balloon 2 and reduce space occupation.
[0084] For further information, see Fig.15 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, each valve body 22 has a chamber connected to the balloon 2. In this way, the valve body 22 can expand (or unfold) after liquid (or gas) is injected into the chamber, and the valve body 22 can shrink (or fold) after the liquid (or gas) in the chamber is removed.
[0085] For further information, see Fig.15As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, each chamber has a first inner wall and a second inner wall respectively; the first inner wall and the second inner wall can fit together under external force to discharge the fluid in the chamber. In this way, after the liquid (or gas) in the chamber is extracted, the first inner wall and the second inner wall can fit together to reduce the volume of the valve body 22, and the first inner wall and the second inner wall can fit together to facilitate the direct transmission of stress between the inner walls of the valve body 22. In one embodiment, the fluid is: liquid or gas.
[0086] For further information, see Fig.15 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, after the balloon 2 is deflated, the multiple petals 22 can be spirally folded. In this way, it is convenient to store the multiple petals 22, and the spirally folded petals 22 can maintain their relative positions more stably through static friction.
[0087] For further information, see Fig.18 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, the outer surface of the balloon 2 is recessed to form a groove 23 for the guide wire 41 to pass through, and the inner space of the groove 23 forms a second guide channel 51. In this way, the guide wire 41 can pass through the groove 23, the groove 23 has a simple structure, and the guide wire 41 is easily stuck in the groove 23 to keep the position of the guide wire 41 stable.
[0088] For further information, see Fig.18 As a specific embodiment of the drug balloon dilatation catheter provided by the present invention, a flexible sheet 7 is laid on the inner wall of the groove 23. In this way, the flexible sheet 7 can reduce the friction between the guide wire 41 and the inner wall of the groove 23, and also reduce the wear of the inner wall of the groove 23 by the guide wire 41.
[0089] The present invention also provides an interventional medical device, including: a pressure source and a drug balloon dilatation catheter; the pressure source is connected to the delivery channel 113. In this way, due to the use of the above-mentioned drug balloon dilatation catheter, the tube body 1 has a delivery channel 113, the tube body 1 has a blood flow channel 123, and the delivery channel 113 and the blood flow channel 123 are isolated from each other; a balloon 2 is arranged on the tube body 1, and the balloon 2 has a receiving chamber 21, and the delivery channel 113 is connected to the receiving chamber 21; liquid (or gas) is injected into the receiving chamber 21 of the balloon 2 through the delivery channel 113 to cause the balloon 2 to expand; before the balloon 2 expands, the user can deliver the balloon 2 to the blood vessel 6; after the balloon 2 expands, the blood vessel 6 can be blocked; the outer surface of the balloon 2 has a drug coating 3, and when the balloon 2 is in After expansion, the drug coating 3 on the surface of the balloon 2 can contact the lesion area 61 on the inner wall of the blood vessel 6, so that the drug on the drug coating 3 can be released to the lesion area 61 on the inner wall of the blood vessel 6; the blood flow inlet 1231 of the blood flow channel 123 can be connected to the upstream blood vessel 6 of the balloon 2, and the blood flow outlet 1232 of the blood flow channel 123 can be connected to the downstream blood vessel 6 of the balloon 2, so that after the balloon 2 blocks the blood vessel 6, the blood upstream of the balloon 2 can still enter the downstream of the balloon 2 through the blood flow channel 123, avoiding the blocking of blood flow in the blood vessel 6 during the process of the drug coating 3 on the balloon 2 contacting the stenotic lesion area 61 and releasing the drug. In addition, after the drug coating 3 on the balloon 2 has completed the release of the drug to the stenotic lesion area 61, if the liquid (or gas) in the balloon 2 is discharged through the delivery channel 113, the deflated balloon 2 can be taken out of the blood vessel 6.
[0090] In one embodiment, the pressure source is: a liquid supply source; the liquid supply source is connected to the delivery channel 113 to inject or discharge liquid into the delivery channel 113.
[0091] In one embodiment, the pressure source is: a gas supply source; the gas supply source is connected to the delivery channel 113 to inject or exhaust gas into the delivery channel 113.
[0092] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and substitutions can be made without departing from the technical principles of the present invention. These improvements and substitutions should also be regarded as the scope of protection of the present invention.
Claims
1. A drug-eluting balloon dilatation catheter, It is characterized in that include: A tube body, a balloon arranged on the tube body, and a drug coating coated on the surface of the balloon; a delivery channel and a blood flow channel are arranged in the tube body; the delivery channel and the blood flow channel are isolated from each other; the balloon has a receiving cavity, the delivery channel is connected to the receiving cavity; the blood flow channel and the receiving cavity are isolated from each other; the blood flow channel includes: a blood flow inlet for communicating with a blood vessel upstream of the balloon and a blood flow outlet for communicating with a blood vessel downstream of the balloon.
2. The drug balloon dilatation catheter according to claim 1, It is characterized in that From the proximal end to the distal end of the tube body, the delivery channel and the blood flow channel are sequentially formed by the inner cavity of the tube body.
3. The drug balloon dilatation catheter according to claim 2, It is characterized in that The blood flow channel runs through the balloon, the blood flow inlet is opened on the side wall of the tube body behind the balloon, and the blood flow outlet is opened on the side wall of the tube body in front of the balloon.
4. The drug balloon dilatation catheter according to claim 1, It is characterized in that The tube body and the balloon are an integrated piece.
5. The drug balloon dilatation catheter according to claim 1, It is characterized in that The cross-section of the blood flow channel may be in any shape of a circle, a semicircle, an ellipse or a polygon.
6. The drug balloon dilatation catheter according to claim 1, It is characterized in that The shape of the blood flow outlet can be any one of circular, semicircular, elliptical and polygonal.
7. The drug balloon dilatation catheter according to claim 1, It is characterized in that The tube body comprises: a first tube and a second tube; the two ends of the first tube are respectively a first end and a second end; the tube cavity in the first tube forms the delivery channel; the two ends of the second tube are respectively a third end and a fourth end; the tube cavity in the second tube forms the blood flow channel; the delivery channel comprises: a delivery inlet and a delivery outlet; the delivery inlet is located on the first end, and the delivery outlet is located on the second end; the blood flow inlet is located on the third end, and the blood flow outlet is located on the fourth end; a through hole is provided on the side wall of the first tube; the third end extends into the delivery channel through the delivery outlet, and the edge of the blood flow inlet is sealed and fixedly connected with the edge of the through hole; the blood flow inlet is communicated with the external space of the first tube through the through hole; the balloon is arranged on the first tube and / or the second tube, and the accommodating cavity is communicated with the delivery outlet; the blood flow inlet is located behind the balloon, and the blood flow outlet is located in front of the balloon.
8. The drug balloon dilatation catheter according to claim 7, It is characterized in that The balloon has a cylindrical body; the two ends of the cylindrical body are respectively a first opening and a second opening; the edge of the first opening is sleeved and fixed on the outer wall of the first tube, or the edge of the first opening is sealed and fixedly connected to the edge of the delivery outlet; the edge of the second opening is sleeved and fixed on the outer wall of the second tube; the accommodating cavity connected to the delivery outlet is formed between the inner wall of the balloon body and the outer wall of the second tube.
9. The drug balloon dilatation catheter according to claim 8, It is characterized in that The accommodating cavity surrounds the outside of the blood flow channel.
10. The drug balloon dilatation catheter according to claim 7, It is characterized in that The number of the blood flow outlets is one or more.
11. The drug balloon dilatation catheter according to claim 10, It is characterized in that The plurality of blood flow outlets are arranged evenly or randomly.
12. The drug balloon dilatation catheter according to claim 10, It is characterized in that At least two of the blood flow outlets are oriented in the same direction.
13. The drug balloon dilatation catheter according to claim 10, It is characterized in that At least two of the blood flow outlets are arranged around and in sequence at intervals outside the blood flow channel; and in the direction surrounding the blood flow channel, the directions of any two adjacent blood flow outlets are arranged at an acute angle.
14. The drug-filled balloon dilatation catheter according to claim 7, It is characterized in that Also includes: A first guide channel for a guide wire to pass through; the first guide channel is arranged on the fourth end; the first guide channel is isolated from the blood flow channel.
15. The drug balloon dilatation catheter according to claim 14, It is characterized in that Also includes: A first guide tube is arranged on the fourth end; the inner space of the first guide tube forms the first guide channel.
16. The drug balloon dilatation catheter according to claim 15, It is characterized in that At least part of the first guide tube is arranged parallel to the blood flow channel; or The first guide tube is located in front of the blood flow channel.
17. The drug balloon dilatation catheter according to claim 15, It is characterized in that Also includes: A second guide channel is provided on the balloon and is used for the guide wire to pass through.
18. The drug balloon dilatation catheter according to claim 17, It is characterized in that The second guide channel passes through the interior of the balloon, and the second guide channel and the accommodating cavity are isolated from each other; or The second guide channel is located outside the balloon.
19. The drug balloon dilatation catheter according to claim 18, It is characterized in that When the second guide channel is located outside the balloon, a second guide tube is provided on the outer surface of the balloon, and the inner space of the second guide tube forms the second guide channel; or When the second guide channel is located outside the balloon, the balloon can surround and cover the outside of the second guide channel after being deflated.
20. The drug balloon dilatation catheter according to claim 18, It is characterized in that When the second guide channel is located outside the balloon, the balloon can be folded into a plurality of petals after being deflated; one or more of the petals can be wrapped around the outside of the second guide channel.
21. The drug balloon dilatation catheter according to claim 20, It is characterized in that Each of the valve bodies has a chamber communicated with the balloon.
22. The drug balloon dilatation catheter according to claim 21, It is characterized in that Each of the chambers has a first inner wall and a second inner wall respectively; the first inner wall and the second inner wall can fit together under external force to discharge the fluid in the chamber.
23. The drug-eluting balloon dilatation catheter according to claim 20, It is characterized in that After the balloon is deflated, the plurality of valve bodies can be folded in a spiral manner.
24. The drug balloon dilatation catheter according to claim 18, It is characterized in that When the second guide channel is located outside the balloon, the outer surface of the balloon is recessed to form a groove for the guide wire to pass through, and the inner space of the groove forms the second guide channel.
25. The drug balloon dilatation catheter according to claim 24, It is characterized in that A flexible sheet is laid on the inner wall of the groove.
26. Interventional medical devices, It is characterized in that include: A pressure source and a drug balloon dilatation catheter as claimed in any one of claims 1 to 25; the pressure source is connected to the delivery channel.
Citation Information
Patent Citations
Drug eluting balloon for the treatment of stenosis and method for manufacturing the balloon
CN103260692A
Balloon catheter provided with side holes
CN106512181A
Drug perfusion balloon dilatation catheter
CN116899083A
Drug perfusion balloon and manufacturing method thereof
CN118634411A
Self-perfusion drug elution balloon and self-perfusion drug elution instrument
CN215690913U
